Return to Listing

2 result(s) for

PI Name Protocol # Title
Koenraad De Geest STUDY00020016 3000-02-006/GOG-3032: A Phase 2 Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and TSR-042 in Patients with Platinum-Resistant Ovarian Cancer (MOONSTONE)
Zahi Mitri STUDY00021243 A Phase 1 Study of Abemaciclib and Niraparib as Neoadjuvant Therapy in Hormone Receptor Positive (HR+) HER2 Negative (HER2-) Breast Cancer

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080